229 related articles for article (PubMed ID: 11531256)
21. Gene aberrations in childhood brain tumors.
Kucerová H; Stejskalová E; Vícha A; Tichý M; Chánová M; Sumerauer D; Koutechký J; Eckschlager T
Folia Biol (Praha); 2000; 46(5):187-90. PubMed ID: 11055797
[TBL] [Abstract][Full Text] [Related]
22. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.
Gajjar A; Hernan R; Kocak M; Fuller C; Lee Y; McKinnon PJ; Wallace D; Lau C; Chintagumpala M; Ashley DM; Kellie SJ; Kun L; Gilbertson RJ
J Clin Oncol; 2004 Mar; 22(6):984-93. PubMed ID: 14970185
[TBL] [Abstract][Full Text] [Related]
23. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.
Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK
BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958
[TBL] [Abstract][Full Text] [Related]
24. Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma.
Traenka C; Remke M; Korshunov A; Bender S; Hielscher T; Northcott PA; Witt H; Ryzhova M; Felsberg J; Benner A; Riester S; Scheurlen W; Grunewald TG; von Deimling A; Kulozik AE; Reifenberger G; Taylor MD; Lichter P; Butt E; Pfister SM
Cancer Res; 2010 Oct; 70(20):8003-14. PubMed ID: 20924110
[TBL] [Abstract][Full Text] [Related]
25. Imbalances of chromosome 17 in medulloblastomas determined by comparative genomic hybridisation and fluorescence in situ hybridisation.
Nicholson J; Wickramasinghe C; Ross F; Crolla J; Ellison D
Mol Pathol; 2000 Dec; 53(6):313-9. PubMed ID: 11193050
[TBL] [Abstract][Full Text] [Related]
26. The effect of isochromosome 17q presence, proliferative and apoptotic indices, expression of c-erbB-2, bcl-2 and p53 proteins on the prognosis of medulloblastoma.
Nam DH; Wang KC; Kim YM; Chi JG; Kim SK; Cho BK
J Korean Med Sci; 2000 Aug; 15(4):452-6. PubMed ID: 10983696
[TBL] [Abstract][Full Text] [Related]
27. Isochromosome 17q, MYC amplification and large cell/anaplastic phenotype in a case of medullomyoblastoma with extracranial metastases.
Wright KD; von der Embse K; Coleman J; Patay Z; Ellison DW; Gajjar A
Pediatr Blood Cancer; 2012 Sep; 59(3):561-4. PubMed ID: 22147345
[TBL] [Abstract][Full Text] [Related]
28. Multiple genomic alterations including N-myc amplification in a primary large cell medulloblastoma.
Reardon DA; Jenkins JJ; Sublett JE; Burger PC; Kun LK
Pediatr Neurosurg; 2000 Apr; 32(4):187-91. PubMed ID: 10940769
[TBL] [Abstract][Full Text] [Related]
29. Prognostic implications of chromosome 17p deletions in human medulloblastomas.
Batra SK; McLendon RE; Koo JS; Castelino-Prabhu S; Fuchs HE; Krischer JP; Friedman HS; Bigner DD; Bigner SH
J Neurooncol; 1995; 24(1):39-45. PubMed ID: 8523074
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome.
Scheurlen WG; Schwabe GC; Joos S; Mollenhauer J; Sörensen N; Kühl J
J Clin Oncol; 1998 Jul; 16(7):2478-85. PubMed ID: 9667267
[TBL] [Abstract][Full Text] [Related]
31. Characterization of chromosome 17 abnormalities in medulloblastomas.
Aldosari N; Rasheed BK; McLendon RE; Friedman HS; Bigner DD; Bigner SH
Acta Neuropathol; 2000 Apr; 99(4):345-51. PubMed ID: 10787031
[TBL] [Abstract][Full Text] [Related]
32. Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma.
Grotzer MA; von Hoff K; von Bueren AO; Shalaby T; Hartmann W; Warmuth-Metz M; Emser A; Kortmann RD; Kuehl J; Pietsch T; Rutkowski S
Klin Padiatr; 2007; 219(6):312-7. PubMed ID: 18050040
[TBL] [Abstract][Full Text] [Related]
33. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma.
Mendrzyk F; Radlwimmer B; Joos S; Kokocinski F; Benner A; Stange DE; Neben K; Fiegler H; Carter NP; Reifenberger G; Korshunov A; Lichter P
J Clin Oncol; 2005 Dec; 23(34):8853-62. PubMed ID: 16314645
[TBL] [Abstract][Full Text] [Related]
34. Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement.
Bien-Willner GA; López-Terrada D; Bhattacharjee MB; Patel KU; Stankiewicz P; Lupski JR; Pfeifer JD; Perry A
Neuro Oncol; 2012 Jul; 14(7):831-40. PubMed ID: 22573308
[TBL] [Abstract][Full Text] [Related]
35. Cytogenetic abnormalities in a disseminated medulloblastoma.
Stuart AG; Pearson AD; Emslie J; Lennard A; Davison EV; Perry RH; Crawford PJ
Med Pediatr Oncol; 1993; 21(4):295-8. PubMed ID: 8469226
[TBL] [Abstract][Full Text] [Related]
36. Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome.
Haberler C; Slavc I; Czech T; Gelpi E; Heinzl H; Budka H; Urban C; Scarpatetti M; Ebetsberger-Dachs G; Schindler C; Jones N; Klein-Franke A; Maier H; Jauk B; Kiefer A; Hainfellner JA
Eur J Cancer; 2006 Nov; 42(17):2996-3003. PubMed ID: 16996732
[TBL] [Abstract][Full Text] [Related]
37. Aggressive medulloblastoma with high-level N-myc amplification.
Tomlinson FH; Jenkins RB; Scheithauer BW; Keelan PA; Ritland S; Parisi JE; Cunningham J; Olsen KD
Mayo Clin Proc; 1994 Apr; 69(4):359-65. PubMed ID: 8170180
[TBL] [Abstract][Full Text] [Related]
38. MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group.
Aldosari N; Bigner SH; Burger PC; Becker L; Kepner JL; Friedman HS; McLendon RE
Arch Pathol Lab Med; 2002 May; 126(5):540-4. PubMed ID: 11958658
[TBL] [Abstract][Full Text] [Related]
39. Correlation of gamma-catenin expression with good prognosis in medulloblastomas.
Misaki K; Marukawa K; Hayashi Y; Fukusato T; Minamoto T; Hasegawa M; Yamashita J; Fujisawa H
J Neurosurg; 2005 Mar; 102(2 Suppl):197-206. PubMed ID: 16156230
[TBL] [Abstract][Full Text] [Related]
40. C-MYC expression in medulloblastoma and its prognostic value.
Herms J; Neidt I; Lüscher B; Sommer A; Schürmann P; Schröder T; Bergmann M; Wilken B; Probst-Cousin S; Hernáiz-Driever P; Behnke J; Hanefeld F; Pietsch T; Kretzschmar HA
Int J Cancer; 2000 Sep; 89(5):395-402. PubMed ID: 11008200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
